Thrombin receptor (PAR-1) antagonists. Heterocycle-based peptidomimetics of the SFLLR agonist motif

被引:32
|
作者
Hoekstra, WJ [1 ]
Hulshizer, BL
McComsey, DF
Andrade-Gordon, P
Kauffman, JA
Addo, MF
Oksenberg, D
Scarborough, RM
Maryanoff, BE
机构
[1] RW Johnson Pharmaceut Res Inst, Spring House, PA 19477 USA
[2] COR Therapeut Inc, S San Francisco, CA 94080 USA
关键词
D O I
10.1016/S0960-894X(98)00292-3
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The thrombin receptor (PAR-I) is activated by a-thrombin to stimulate various cell types, including platelets, through the tethered-ligand sequence SFLLRN. A series of azole-based carboxamides, designed after SFLLR, were synthesized and evaluated in vitro. The compounds inhibited platelet aggregation induced by SFLLRN-NH2 or a-thrombin, and blocked the binding of [H-3]-S-(p-F-Phe)-Har-L-Har-KY-NH2 to a CHRF membrane preparation of PAR-I. Oxazole 30 bound to PAR-I with an IC50 Of 1.6 mu M, and gave IC50 values of 25 mu M and 6.6 mu M against alpha-thrombin- and SFLLRN-NH2-induced platelet aggregation, respectively. (C) 1998 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:1649 / 1654
页数:6
相关论文
共 50 条
  • [1] Novel indole-based peptidomimetics as potent thrombin receptor (PAR-1) antagonists.
    Zhang, HC
    Hoekstra, WJ
    Maryanoff, BE
    McComsey, DF
    Poulter, BL
    White, KB
    Addo, MF
    Andrade-Gordon, P
    Derian, CK
    Oksenberg, D
    Reynolds, EE
    Scarborough, RM
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1999, 218 : U910 - U910
  • [2] Discovery and optimization of potent orally active small molecular thrombin receptor(PAR-1) antagonists.
    Kawahara, T
    Suzuki, S
    Matsuura, F
    Clark, RSJ
    Kogushi, M
    Kobayashi, H
    Hishinuma, L
    Sato, N
    Terauchi, T
    Kajiwara, A
    Matsuoka, T
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2004, 227 : U21 - U21
  • [3] Discovery and optimization of potent orally active small molecular thrombin receptor PAR-1 antagonists.
    Kawahara, T
    Suzuki, S
    Kogushi, M
    Matsuoka, T
    Kobayashi, H
    Kajiwara, A
    Hishinuma, I
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2003, 225 : U215 - U215
  • [4] Thrombin receptor (PAR-1) antagonists as novel antithrombotic agents
    Chackalamannil, S
    Xia, Y
    EXPERT OPINION ON THERAPEUTIC PATENTS, 2006, 16 (04) : 493 - 505
  • [5] Thrombin receptor (PAR-1) antagonists as antithrombotic agents.
    Zhang, HC
    Maryanoff, BE
    Derian, CK
    Andrade-Gordon, P
    McComsey, DF
    Hoekstra, WJ
    White, KB
    Poulter, BL
    Damiano, BP
    Addo, MF
    Cheung, WM
    Darrow, AL
    D'Andrea, MR
    Oksenberg, D
    Reynolds, EE
    Pandey, A
    Scarborough, RM
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2003, 226 : U6 - U7
  • [6] Design and synthesis of novel himbacine based thrombin receptor (Par-1) antagonists
    Chelliah, Mariappan V.
    Chackalamannil, Samuel
    Xia, Yan
    Eagen, Keith
    Tsai, Hsingan
    Clasby, Martin
    Gao, Xiaobang
    Greenlee, William J.
    Ahn, Ho-Sam
    Boykow, George
    Foster, Carolyn
    Hsieh, Yunsheng
    Agans-Fantuzzi, Jacqueline
    Bryant, Matthew
    Chintala, Madhu
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2006, 231
  • [7] Thrombin receptor (PAR-1) antagonists. Solid-phase synthesis of indole-based peptide mimetics by anchoring to a secondary amide
    Zhang, HC
    McComsey, DF
    White, KB
    Addo, MF
    Andrade-Gordon, P
    Derian, CK
    Oksenberg, D
    Maryanoff, BE
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2001, 11 (16) : 2105 - 2109
  • [8] Thrombin receptor antagonists; Recent advances in PAR-1 antagonist development
    Anderluh, M
    Dolenc, MS
    CURRENT MEDICINAL CHEMISTRY, 2002, 9 (13) : 1229 - 1250
  • [9] Macrocyclic hexapeptide analogues of the thrombin receptor (PAR-1) activation motif SFLLRN
    McComsey, DF
    Hecker, LR
    Andrade-Gordon, P
    Addo, MF
    Maryanoff, BE
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1999, 9 (02) : 255 - 260
  • [10] Discovery and synthesis of a novel series of quinoline-based thrombin receptor (PAR-1) antagonists
    Clasby, MC
    Chackalamannil, S
    Czarniecki, M
    Doller, D
    Eagen, K
    Greenlee, WJ
    Lin, Y
    Tsai, H
    Xia, Y
    Ahn, HS
    Agans-Fantuzzi, J
    Boykow, G
    Chintala, M
    Foster, C
    Bryant, M
    Lau, J
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2006, 16 (06) : 1544 - 1548